PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $35,860 | -61.6% | 11,000 | -37.5% | 0.01% | -66.7% |
| Q1 2024 | $93,280 | -63.8% | 17,600 | -70.4% | 0.02% | -68.8% |
| Q4 2023 | $257,635 | +46.2% | 59,500 | -11.2% | 0.05% | +33.3% |
| Q3 2023 | $176,210 | -24.1% | 67,000 | -7.8% | 0.04% | -18.2% |
| Q2 2023 | $232,168 | +108.7% | 72,700 | +101.9% | 0.04% | +91.3% |
| Q1 2023 | $111,240 | -7.7% | 36,000 | +26.3% | 0.02% | +43.8% |
| Q4 2022 | $120,555 | +0.5% | 28,500 | -43.6% | 0.02% | -44.8% |
| Q3 2022 | $120,000 | -24.1% | 50,500 | -9.0% | 0.03% | -9.4% |
| Q2 2022 | $158,000 | -1.2% | 55,500 | 0.0% | 0.03% | +14.3% |
| Q1 2022 | $160,000 | -11.6% | 55,500 | -6.7% | 0.03% | -6.7% |
| Q4 2021 | $181,000 | – | 59,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |